Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma
- PMID:20636790
- DOI: 10.1111/j.1365-2559.2010.03560.x
Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma
Abstract
Aims: Monocarboxylate transporters (MCTs) have been considered promising targets for cancer therapy, since they facilitate lactate efflux in glycolytic tumours. However, their role in solid tumours is still poorly understood. Thus, the present work aimed to contribute to understanding the involvement of MCT1 and MCT4 in breast cancer progression as well as MCT regulation by CD147.
Methods and results: The expression of the membrane transporters MCT1 and MCT4 was analysed in a series of breast carcinomas (249 cases) and their clinicopathological significance investigated. Additionally, we analysed the significance of CD147 co-expression, as an important regulator of MCT expression and activity. MCT1 was significantly increased in breast carcinomas when compared with normal breast tissue and, importantly, both MCT1 and CD147 were associated with poor prognostic variables such as basal-like subtype and high grade tumours.
Conclusions: These results provide evidence for a prognostic value of MCT1 in breast carcinoma and support the exploitation of the complex MCT1/CD147 as a promising target for cancer therapy, especially in basal-like breast carcinoma.
Similar articles
- The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer.Pinheiro C, Longatto-Filho A, Simões K, Jacob CE, Bresciani CJ, Zilberstein B, Cecconello I, Alves VA, Schmitt F, Baltazar F.Pinheiro C, et al.Eur J Cancer. 2009 Sep;45(13):2418-24. doi: 10.1016/j.ejca.2009.06.018. Epub 2009 Jul 21.Eur J Cancer. 2009.PMID:19628385
- CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models.Schneiderhan W, Scheler M, Holzmann KH, Marx M, Gschwend JE, Bucholz M, Gress TM, Seufferlein T, Adler G, Oswald F.Schneiderhan W, et al.Gut. 2009 Oct;58(10):1391-8. doi: 10.1136/gut.2009.181412. Epub 2009 Jun 7.Gut. 2009.PMID:19505879
- Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.Kim Y, Choi JW, Lee JH, Kim YS.Kim Y, et al.Hum Pathol. 2015 Jan;46(1):104-12. doi: 10.1016/j.humpath.2014.09.013. Epub 2014 Oct 7.Hum Pathol. 2015.PMID:25456395
- Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis.Bovenzi CD, Hamilton J, Tassone P, Johnson J, Cognetti DM, Luginbuhl A, Keane WM, Zhan T, Tuluc M, Bar-Ad V, Martinez-Outschoorn U, Curry JM.Bovenzi CD, et al.Biomed Res Int. 2015;2015:242437. doi: 10.1155/2015/242437. Epub 2015 Dec 8.Biomed Res Int. 2015.PMID:26779534Free PMC article.Review.
- The monocarboxylate transporter family--role and regulation.Halestrap AP, Wilson MC.Halestrap AP, et al.IUBMB Life. 2012 Feb;64(2):109-19. doi: 10.1002/iub.572. Epub 2011 Dec 9.IUBMB Life. 2012.PMID:22162139Review.
Cited by
- CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells.Walters DK, Arendt BK, Jelinek DF.Walters DK, et al.Cell Cycle. 2013 Oct 1;12(19):3175-83. doi: 10.4161/cc.26193. Epub 2013 Sep 3.Cell Cycle. 2013.PMID:24013424Free PMC article.
- Monocarboxylate transporter-1 (MCT1) protein expression in head and neck cancer affects clinical outcome.Leu M, Kitz J, Pilavakis Y, Hakroush S, Wolff HA, Canis M, Rieken S, Schirmer MA.Leu M, et al.Sci Rep. 2021 Feb 25;11(1):4578. doi: 10.1038/s41598-021-84019-w.Sci Rep. 2021.PMID:33633176Free PMC article.
- Exercise-induced changes in tumour LDH-B and MCT1 expression are modulated by oestrogen-related receptor alpha in breast cancer-bearing BALB/c mice.Aveseh M, Nikooie R, Aminaie M.Aveseh M, et al.J Physiol. 2015 Jun 15;593(12):2635-48. doi: 10.1113/JP270463. Epub 2015 May 18.J Physiol. 2015.PMID:25907793Free PMC article.
- Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs).de Oliveira AT, Pinheiro C, Longatto-Filho A, Brito MJ, Martinho O, Matos D, Carvalho AL, Vazquez VL, Silva TB, Scapulatempo C, Saad SS, Reis RM, Baltazar F.de Oliveira AT, et al.J Bioenerg Biomembr. 2012 Feb;44(1):171-8. doi: 10.1007/s10863-012-9408-5. Epub 2012 Jan 27.J Bioenerg Biomembr. 2012.PMID:22281667
- Lactate Beyond a Waste Metabolite: Metabolic Affairs and Signaling in Malignancy.Baltazar F, Afonso J, Costa M, Granja S.Baltazar F, et al.Front Oncol. 2020 Mar 18;10:231. doi: 10.3389/fonc.2020.00231. eCollection 2020.Front Oncol. 2020.PMID:32257942Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical